Solventum Corp. (SOLV)
87.85
+0.08
(+0.09%)
USD |
NYSE |
Oct 02, 16:00
87.86
+0.01
(+0.01%)
Pre-Market: 20:00
Solventum Enterprise Value : 19.83B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 19.83B |
| October 01, 2026 | 19.81B |
| September 30, 2026 | 19.88B |
| September 29, 2026 | 20.08B |
| September 28, 2026 | 20.11B |
| September 25, 2026 | 20.11B |
| September 24, 2026 | 19.95B |
| September 23, 2026 | 19.92B |
| September 22, 2026 | 19.98B |
| September 21, 2026 | 20.00B |
| September 18, 2026 | 20.00B |
| September 17, 2026 | 19.77B |
| September 16, 2026 | 19.99B |
| September 15, 2026 | 20.20B |
| September 14, 2026 | 20.16B |
| September 11, 2026 | 19.76B |
| September 10, 2026 | 19.79B |
| September 09, 2026 | 20.20B |
| September 08, 2026 | 20.21B |
| September 04, 2026 | 20.48B |
| September 03, 2026 | 20.61B |
| September 02, 2026 | 20.52B |
| September 01, 2026 | 20.35B |
| August 31, 2026 | 20.37B |
| August 28, 2026 | 20.38B |
| Date | Value |
|---|---|
| August 27, 2026 | 20.35B |
| August 26, 2026 | 20.45B |
| August 25, 2026 | 20.47B |
| August 24, 2026 | 20.41B |
| August 21, 2026 | 20.12B |
| August 20, 2026 | 19.96B |
| August 19, 2026 | 19.82B |
| August 18, 2026 | 19.76B |
| August 17, 2026 | 19.65B |
| August 14, 2026 | 19.95B |
| August 13, 2026 | 19.59B |
| August 12, 2026 | 19.39B |
| August 11, 2026 | 19.19B |
| August 10, 2026 | 19.38B |
| August 07, 2026 | 19.00B |
| August 06, 2026 | 19.00B |
| August 05, 2026 | 19.76B |
| August 04, 2026 | 19.84B |
| August 03, 2026 | 19.86B |
| July 31, 2026 | 19.42B |
| July 30, 2026 | 19.65B |
| July 29, 2026 | 19.95B |
| July 28, 2026 | 19.54B |
| July 27, 2026 | 18.57B |
| July 24, 2026 | 18.15B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Stryker Corp. | 117.62B |
| Zimmer Biomet Holdings, Inc. | 23.91B |
| IDEXX Laboratories, Inc. | 41.79B |
| Intuitive Surgical, Inc. | 133.59B |
| Inspire Medical Systems, Inc. | 1.731B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 92.00M |
| Revenue (Quarterly) | 2.209B |
| Total Expenses (Quarterly) | 2.117B |
| EPS Diluted (Quarterly) | 0.5309 |
| Gross Profit Margin (Quarterly) | 58.44% |
| Profit Margin (Quarterly) | 4.16% |
| Earnings Yield | 9.31% |
| Operating Earnings Yield | 4.59% |
| Normalized Earnings Yield | 10.54 |